The aurora kinase inhibitor CCT137690 triggers necroptosis in pancreatic cancer cells through RIPK1, RIPK3, and MLKL and thus suppresses tumor growth (Xie et al., 2017). This evidence concerns the gene RIPK1 and pancreatic neoplasm.